The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 01, 2023
Filed:
Dec. 16, 2016
Applicant:
Oncosec Medical Incorporated, Pennington, NJ (US);
Inventors:
Jean Campbell, Seattle, WA (US);
David A. Canton, Poway, CA (US);
Robert H. Pierce, San Diego, CA (US);
Assignee:
OncoSec Medical Incorporated, Ewing, NJ (US);
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/85 (2006.01); C07K 14/54 (2006.01); C07K 14/52 (2006.01); C07K 14/715 (2006.01); A61K 9/00 (2006.01); A61P 35/00 (2006.01); C07K 14/57 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
C12N 15/85 (2013.01); A61K 9/0009 (2013.01); A61K 9/0019 (2013.01); A61P 35/00 (2018.01); C07K 14/52 (2013.01); C07K 14/5434 (2013.01); C07K 14/5443 (2013.01); C07K 14/57 (2013.01); C07K 14/7155 (2013.01); G01N 33/574 (2013.01); C07K 2319/00 (2013.01);
Abstract
Provided are plasmid vector constructs encoding multiple immunomodulatory proteins where each protein or component thereof can be expressed utilizing appropriate promotors and/or translation modifiers. Additional immunomodulatory proteins and genetic adjuvants containing shared tumor antigens can be added to further therapeutic potential as well as allow tracking of therapeutic treatment. Also provides are methods of expressing the plasmid constructs.